Angiogenesis in cancer, vascular, rheumatoid and other disease
The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Recent discoveries of endogenous negative regulators of angiogenesis, thrombospondin, angiostatin and glioma-derived angiogenesis inhibitory factor, all associated with neovascularized tumours, suggest a new paradigm of tumorigenesis. It is now helpful to think of the switch to the angiogenic phenotype as a net balance of positive and negative regulators of blood vessel growth. The extent to which the negative regulators are decreased during this switch may dictate whether a primary tumour grows rapidly or slowly and whether metastases grow at all.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma
Weidner, N., Semple, J. P., Welch, W. R., & Folkman, J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101033240101 · Cited by 5,627
Self-citationVascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
What Is the Evidence That Tumors Are Angiogenesis Dependent?
Folkman, J. (1990) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/82.1.4 · Cited by 4,531
Self-citationTumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
O'Reilly, M. (1994) · Cell · doi:10.1016/0092-8674(94)90200-3 · Cited by 3,345
Folkman, J., & Shing, Y. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49853-0 · Cited by 2,654
Self-citationThalidomide is an inhibitor of angiogenesis.
D'Amato, R. J., Loughnan, M. S., Flynn, E., & Folkman, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.4082 · Cited by 2,454
Self-citationPlate, K. H., Breier, G., Weich, H. A., & Risau, W. (1992) · Nature · doi:10.1038/359845a0 · Cited by 2,275
Ferrara, N., & Henzel, W. J. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92678-8 · Cited by 2,268
Millauer, B., Wizigmann-Voos, S., Schnürch, H., Martinez, R., Møller, N. P. H., Risau, W., & Ullrich, A. (1993) · Cell · doi:10.1016/0092-8674(93)90573-9 · Cited by 1,927
Research works printed but not linked: 9
- Holmgren, L., O'Reilly, M. & Folkman, J. in press (1994).
- Kohn, E. et al. Phase I trial of signal transduction inhibitor, CAI. Proc. Amer. Assoc. Cancer Res. 35,244(1994).
- Folkman, J. Clinical applications of angiogenesis research. New Engl. J. Med. in press (1994).
- Watanabe, H., Nguyen, M., Schizer, M., Li, V., Hayes, D.R., Sallan, S., Folkman, J. Basic fibroblast growth factor in human serum – a prognostic test for breast cancer. Molec. Biol. Cell 3, 324a (1992).
- Szabo, S. et al. Orally administered FGF mutein: Effect on healing of chronic duodenal ulcers in rats. Digestive Disease and Sciences 34, 1323 (1989).
- Hull, M.A., Cullen, D.J.E. & Hawkey, C.J. Basic fibroblast growth factor in gastric ulceration: mucosal levels and therapeutic potential. Gastroenterology 106, A97 (1994).
- Wolfe, M.M. et al. Safety and efficacy of an angiogenic peptide, basic fibroblast growth factor (bFGF) in the treatment of gastroduodenal ulcers: A preliminary report. Gastroenterology 106, A212 (1994).
- Brem, H., Goto, F., Budson, A., Saunders, L. & Folkman, J. Minimal drug resistance after prolonged antiangiogenic therapy with AGM-1470. Surgical Forum XLV, 674–677 (1994).
- O'Reilly, M.S. et al. (unpublished data).
Cited by
Items 1,001–1,046 of 1,046
Lowther, W. T., Orville, A. M., Madden, D. T., Lim, S., Rich, D. H., & Matthews, B. W. (1999) · Biochemistry · doi:10.1021/bi990684r · Cited by 147
Expression of angiopoietin-2 in human glioma cells and its role for angiogenesis.
Koga, K., Todaka, T., Morioka, M., Hamada, J., Kai, Y., Yano, S., Okamura, A., Takakura, N., Suda, T., & Ushio, Y. (2001) · PubMed · Cited by 166
Rabinowich, H., Suminami, Y., Reichert, T. E., Crowley-Nowick, P., Bell, M., Edwards, R., & Whiteside, T. L. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19961104)68:3<276::aid-ijc2>3.0.co;2-z · Cited by 97
Antitumor Peptides from Marine Organisms
Zheng, L.-H., Wang, Y.-J., Sheng, J., Wang, F., Zheng, Y., Lin, X.-K., & Sun, M. (2011) · Marine Drugs · doi:10.3390/md9101840 · Cited by 146
“Both tumor growth and metastasis depend on the expansion of host vasculatures into tumors through angiogenesis [76–79].”
BackgroundKatagiri, A., Fu, K., Sano, Y., Ikematsu, H., Horimatsu, T., Kaneko, K., Muto, M., & Yoshida, S. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03650.x · Cited by 158
Review: in vitro microvessel models
Bogorad, M. I., DeStefano, J., Karlsson, J., Wong, A. D., Gerecht, S., & Searson, P. C. (2015) · Lab on a Chip · doi:10.1039/c5lc00832h · Cited by 145
Genome Editing Abrogates Angiogenesis in Vivo
Huang, X., Zhou, G., Wu, W., Duan, Y., Ma, G., Song, J., Xiao, R., Vandenberghe, L., Zhang, F., D’Amore, P. A., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00140-3 · Cited by 142
RGD peptide-based non-viral gene delivery vectors targeting integrin α v β 3 for cancer therapy
Fu, S., Xu, X., Ma, Y., Zhang, S., & Zhang, S. (2019) · Journal of drug targeting · doi:10.1080/1061186x.2018.1455841 · Cited by 139
“It is a key requirement for tumour growth and metastasis, tumour angiogenesis could potentially be utilised for cancer therapy [8].”
BackgroundTumor cells and their crosstalk with endothelial cells in 3D spheroids
Shoval, H., Karsch-Bluman, A., Brill-Karniely, Y., Stern, T., Zamir, G., Hubert, A., & Benny, O. (2017) · Scientific Reports · doi:10.1038/s41598-017-10699-y · Cited by 138
Zhao, Q., Egashira, K., Inoue, S., Usui, M., Kitamoto, S., Ni, W., Ishibashi, M., Hiasa, K.-I., Ichiki, T., Shibuya, M., et al. (2002) · Circulation · doi:10.1161/hc0902.104718 · Cited by 136
Obstacles facing translational research in academic medical centers
POBER, J. S., NEUHAUSER, C. S., & POBER, J. M. (2001) · The FASEB Journal · doi:10.1096/fj.01-0540lsf · Cited by 132
Wada, H., Nagano, H., Yamamoto, H., Yang, Y., Kondo, M., Ota, H., Nakamura, M., Yoshioka, S., Kato, H., Damdinsuren, B., et al. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01243.x · Cited by 130
Zhang, E. G., Smith, S. K., Baker, P. N., & Charnock-Jones, D. S. (2001) · Molecular Medicine · doi:10.1007/bf03401869 · Cited by 125
Tumor-on-a-chip for integrating a 3D tumor microenvironment: chemical and mechanical factors
Wan, L., Neumann, C. A., & LeDuc, P. R. (2020) · Lab on a Chip · doi:10.1039/c9lc00550a · Cited by 120
Smits, M., Mir, S. E., Nilsson, R. J. A., van der Stoop, P. M., Niers, J. M., Marquez, V. E., Cloos, J., Breakefield, X. O., Krichevsky, A. M., Noske, D. P., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016282 · Cited by 118
Angiogenesis and Macrophage Activation in Endometriosis
TAYLOR, R. N., RYAN, S. P., MOORE, E. S., HORNUNG, D., SHIFREN, J. L., & TSENG, J. F. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48540.x · Cited by 113
The role of homeobox genes in vascular remodeling and angiogenesis
Gorski, D. H., & Walsh, K. (2000) · Circulation Research · doi:10.1161/01.res.87.10.865 · Cited by 110
Anti-angiogenic effect of siphonaxanthin from green alga, Codium fragile
Ganesan, P., Matsubara, K., Ohkubo, T., Tanaka, Y., Noda, K., Sugawara, T., & Hirata, T. (2010) · Phytomedicine · doi:10.1016/j.phymed.2010.05.005 · Cited by 112
Takenaka, K., Ishikawa, S., Kawano, Y., Yanagihara, K., Miyahara, R., Otake, Y., Morioka, Y., Takahashi, C., Noda, M., Wada, H., et al. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.02.028 · Cited by 104
Miyake, M., Goodison, S., Lawton, A., Gomes-Giacoia, E., & Rosser, C. J. (2015) · Oncogene · doi:10.1038/onc.2014.2 · Cited by 103
Ogawara, K.-I., Un, K., Tanaka, K.-I., Higaki, K., & Kimura, T. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.09.008 · Cited by 101
Reactive Oxygen Species a Double-Edged Sword for Mesothelioma
Benedetti, S., Nuvoli, B., Catalani, S., & Galati, R. (2015) · Oncotarget · doi:10.18632/oncotarget.4253 · Cited by 97
“To develop a stable blood supply for tumor growth, many cells in the tumor microenvironment, including tumor epithelial cells, stromal cells, and immune cells, secrete various proangiogenic factors that stimulate endothelial cell recruitment, proliferation, migration, and tubule formation [120].”
BackgroundMicrometastases: marker of metastatic potential or evidence of residual disease?
O'Sullivan, G. C., Collins, J. K., Kelly, J., Morgan, J., Madden, M., & Shanahan, F. (1997) · Gut · doi:10.1136/gut.40.4.512 · Cited by 91
Review of Photoacoustic Flow Imaging: Its Current State and Its Promises
van den Berg, P. J., Daoudi, K., & Steenbergen, W. (2015) · Photoacoustics · doi:10.1016/j.pacs.2015.08.001 · Cited by 84
Circulating Endothelial Progenitor Cells Are Up-Regulated in a Mouse Model of Endometriosis
Becker, C. M., Beaudry, P., Funakoshi, T., Benny, O., Zaslavsky, A., Zurakowski, D., Folkman, J., D'Amato, R. J., & Ryeom, S. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2010.12.037 · Cited by 81
“25 Considerable debate currently exists about the contribution of EPCs to neovascularization of tumors.”
BackgroundSelf-citationTei, K., Matsumoto, T., Mifune, Y., Ishida, K., Sasaki, K., Shoji, T., Kubo, S., Kawamoto, A., Asahara, T., Kurosaka, M., et al. (2008) · Stem Cells · doi:10.1634/stemcells.2007-0671 · Cited by 78
The dual roles of homeobox genes in vascularization and wound healing
Kachgal, S., Mace, K. A., & Boudreau, N. J. (2012) · Cell Adhesion & Migration · doi:10.4161/cam.22164 · Cited by 72
STIM-Orai Channels and Reactive Oxygen Species in the Tumor Microenvironment
Frisch, J., Angenendt, A., Hoth, M., Prates Roma, L., & Lis, A. (2019) · Cancers · doi:10.3390/cancers11040457 · Cited by 68
“Low oxygen tension (hypoxia) promotes metastasis and is considered as the key driver in angiogenesis [101,102].”
BackgroundAdiponectin as a tissue regenerating hormone: More than a metabolic function
Fiaschi, T., Magherini, F., Gamberi, T., Modesti, P. A., & Modesti, A. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1537-4 · Cited by 66
Lorgis, V., Maura, G., Coppa, G., Hassani, K., Taillandier, L., Chauffert, B., Apetoh, L., Ladoire, S., & Ghiringhelli, F. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0748-5 · Cited by 60
Kurebayashi, J., Otsuki, T., Kurosumi, M., Soga, S., Akinaga, S., & Sonoo, H. (2001) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2001.tb02159.x · Cited by 60
Walsh, D. A., Catravas, J., & Wharton, J. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.2.125 · Cited by 57
Ding, C., Li, L., Yang, T., Fan, X., & Wu, G. (2016) · BMC Cancer · doi:10.1186/s12885-016-2834-8 · Cited by 56
Berrahmoune, H., Lamont, J. V., Herbeth, B., FitzGerald, P. S., & Visvikis-Siest, S. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.055798 · Cited by 56
Interferons: role in cancer therapy
Abdolvahab, M. H., Darvishi, B., Zarei, M., Majidzadeh-A, K., & Farahmand, L. (2020) · Immunotherapy · doi:10.2217/imt-2019-0217 · Cited by 50
Involvement of RB gene family in tumor angiogenesis
Gabellini, C., Del Bufalo, D., & Zupi, G. (2006) · Oncogene · doi:10.1038/sj.onc.1209631 · Cited by 47
“…between several factors promoting or suppressing angiogenesis and the induction of the so-called ‘angiogenic switch’ is determined by proangiogenic factors overcoming the antiangiogenic ones (Folkman, 1995; Beck and D’Amore, 1997; Ferrara, 2000; Kerbel, 2000; Li et al., 2000, Tonini et al., 2003).”
BackgroundThe Potential Role of Sildenafil in CancerManagement Through EPR Augmentation
Haider, M., Elsherbeny, A., Pittalà, V., Fallica, A. N., Alghamdi, M. A., & Greish, K. (2021) · doi:10.20944/preprints202104.0679.v1 · Cited by 42
Tumor rim cells: From resistance to vascular targeting agents to complete tumor ablation
Seidi, K., Jahanban-Esfahlan, R., & Zarghami, N. (2017) · Tumor Biology · doi:10.1177/1010428317691001 · Cited by 41
Clinical trials with anti‐angiogenic agents in hematological malignancies
Medinger, M., & Mross, K. (2010) · Journal of Angiogenesis Research · doi:10.1186/2040-2384-2-10 · Cited by 40
“Introduction The hypothesis of tumor angiogenesis in malignancies was raised by Judah Folkman: To grow over a certain size of a few millimetres in diameter solid tumors need blood supply from surrounding vessel [1].”
Xu, M.-J., Song, P., Shirwany, N., Liang, B., Xing, J., Viollet, B., Wang, X., Zhu, Y., & Zou, M.-H. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.227991 · Cited by 39
Control of angiogenesis dictated by picomolar superoxide levels
Bir, S. C., Shen, X., Kavanagh, T. J., Kevil, C. G., & Pattillo, C. B. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.05.015 · Cited by 30
“), and signaling mediators (Akt, ERK 1/2, and others), which drive other cellular responses including activation, proliferation, migration and maturation of endothelial cells [1, 2].”
BackgroundPrevention of liver fibrosis and liver reconstitution of DMN‐treated rat liver by transplanted EPCs
Nakamura, T., Torimura, T., Iwamoto, H., Masuda, H., Naitou, M., Koga, H., Abe, M., Hashimoto, O., Tsutsumi, V., Ueno, T., et al. (2012) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2011.02637.x · Cited by 27
Role of endothelial cell-selective adhesion molecule in hematogeneous metastasis
Cangara, H. M., Ishida, T., Hara, T., Sun, L., Toh, R., Rikitake, Y., Kundu, R. K., Quertermous, T., Hirata, K.-I., & Hayashi, Y. (2010) · Microvascular Research · doi:10.1016/j.mvr.2010.02.006 · Cited by 23
Effects of repeated propranolol administration in a rat model of surgically induced endometriosis
Uzunlar, O., Ozyer, S., Engin-Ustun, Y., Moraloglu, O., Gulerman, H. C., Caydere, M., Keskin, S. M., & Mollamahmutoglu, L. (2014) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2014.09.025 · Cited by 14
“Endometriotic lesions are known to stimulate angiogenesis and neovascularization [25].”
BackgroundAhn, J., Sei, Y. J., Jeon, N. L., & Kim, Y. (2018) · IEEE Transactions on Nanotechnology · doi:10.1109/tnano.2017.2771426 · Cited by 14
“and differentiation of endothelial cells [12].”
Nabarra, B., Pontoux, C., Godard, C., Osborne‐Pellegrin, M., & Ezine, S. (2005) · International Journal of Experimental Pathology · doi:10.1111/j.0959-9673.2005.00451.x · Cited by 3
Metadata
- Authors
- Folkman, J.
- Affiliations
- Boston Children's Hospital (US)
- Corresponding author
- Folkman, Judah
- Venue
- Nature Medicine
- Published
- 1995-01
- Volume
- 1
- Issue
- 1
- Pages
- 27-30
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2000000541
- Semantic Scholar
- 20a719a4d594caa54b1faa591d81eacb3f8d75c1
- Cited by
- 7,627
- References
- 62
- Citations by year
- 2026: 27 · 2025: 47 · 2024: 89 · 2023: 85 · 2022: 104 · 2021: 133 · 2020: 116 · 2019: 147 · 2018: 135 · 2017: 195 · 2016: 186 · 2015: 215 · 2014: 276 · 2013: 300 · 2012: 294
- FWCI
- 16.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Health Sciences › Medicine › Oncology › Vascular Tumors and Angiosarcomas
- Keywords
- angiogenesis, tumor angiogenesis, angiogenic switch, thrombospondin, angiostatin, carcinogenesis, metastasis, vascular disease, rheumatoid arthritis
- MeSH terms
- Animals, Arthritis, Rheumatoid, Eye, Humans, Lymphokines, Neoplasm Metastasis, Neoplasms, Neovascularization, Pathologic, Peptide Fragments, Plasminogen, Psoriasis, Time Factors, Endothelial Growth Factors, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A, Angiostatins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.